|
RIOK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.685000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.155800E-01 |
| Normal-vs-Stage2 |
2.584200E-01 |
| Normal-vs-Stage3 |
4.338200E-01 |
| Normal-vs-Stage4 |
8.711800E-01 |
| Stage1-vs-Stage2 |
3.385600E-02 |
| Stage1-vs-Stage3 |
7.358600E-01 |
| Stage1-vs-Stage4 |
4.578400E-01 |
| Stage2-vs-Stage3 |
7.019800E-02 |
| Stage2-vs-Stage4 |
2.496000E-01 |
| Stage3-vs-Stage4 |
6.274400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.414200E-01 |
| Normal-vs-AfricanAmerican |
8.902400E-02 |
| Normal-vs-Asian |
4.339000E-01 |
| Caucasian-vs-AfricanAmerican |
1.791390E-01 |
| Caucasian-vs-Asian |
9.805800E-01 |
| AfricanAmerican-vs-Asian |
2.714400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.455360E-01 |
| Normal-vs-Female |
5.851600E-01 |
| Male-vs-Female |
2.149000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.743900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.944000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.214800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.593400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.350400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.607600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.961000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.965000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.368600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.758000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.957400E-01 |
| Classical-VS-Follicular |
8.57430000333892E-08 |
| Classical-VS-Other |
4.761800E-01 |
| Classical-VS-Normal |
2.460500E-02 |
| Tall-VS-Follicular |
1.084120E-03 |
| Tall-VS-Other |
3.483800E-01 |
| Tall-VS-Normal |
7.772400E-02 |
| Follicular-VS-Other |
9.790100E-02 |
| Follicular-VS-Normal |
1.480250E-02 |
| Other-VS-Normal |
9.585800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.246200E-01 |
| Normal-vs-N1 |
1.591350E-01 |
| N0-vs-N1 |
4.587900E-02 |
|
|
